Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2010

Open Access 01-12-2010 | Correspondence

The use of economic evaluation in CAM: an introductory framework

Authors: Emily Ford, Daniela Solomon, Jon Adams, Nicholas Graves

Published in: BMC Complementary Medicine and Therapies | Issue 1/2010

Login to get access

Abstract

Background

For CAM to feature prominently in health care decision-making there is a need to expand the evidence-base and to further incorporate economic evaluation into research priorities.
In a world of scarce health care resources and an emphasis on efficiency and clinical efficacy, CAM, as indeed do all other treatments, requires rigorous evaluation to be considered in budget decision-making.

Methods

Economic evaluation provides the tools to measure the costs and health consequences of CAM interventions and thereby inform decision making. This article offers CAM researchers an introductory framework for understanding, undertaking and disseminating economic evaluation. The types of economic evaluation available for the study of CAM are discussed, and decision modelling is introduced as a method for economic evaluation with much potential for use in CAM. Two types of decision models are introduced, decision trees and Markov models, along with a worked example of how each method is used to examine costs and health consequences. This is followed by a discussion of how this information is used by decision makers.

Conclusions

Undoubtedly, economic evaluation methods form an important part of health care decision making. Without formal training it can seem a daunting task to consider economic evaluation, however, multidisciplinary teams provide an opportunity for health economists, CAM practitioners and other interested researchers, to work together to further develop the economic evaluation of CAM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hulme C, Long AF: Square pegs and round holes? A review of economic evaluation in complementary and alternative medicine. The Journal of Alternative and Complementary Medicine. 2005, 11: 179-188. 10.1089/acm.2005.11.179.CrossRefPubMed Hulme C, Long AF: Square pegs and round holes? A review of economic evaluation in complementary and alternative medicine. The Journal of Alternative and Complementary Medicine. 2005, 11: 179-188. 10.1089/acm.2005.11.179.CrossRefPubMed
2.
go back to reference Van Haselen R: Complementary or alternative medicine: towards establishing value for money. Complementary Therapies in Medicine. 2006, 14: 1-2. 10.1016/j.ctim.2006.01.002.CrossRefPubMed Van Haselen R: Complementary or alternative medicine: towards establishing value for money. Complementary Therapies in Medicine. 2006, 14: 1-2. 10.1016/j.ctim.2006.01.002.CrossRefPubMed
3.
go back to reference Adams J: Utilising and promoting public health and health services research in complementary and alternative medicine: the founding of NORPHCAM. Complementary Therapies in Medicine. 2008, 16: 245-246. 10.1016/j.ctim.2008.08.002.CrossRefPubMed Adams J: Utilising and promoting public health and health services research in complementary and alternative medicine: the founding of NORPHCAM. Complementary Therapies in Medicine. 2008, 16: 245-246. 10.1016/j.ctim.2008.08.002.CrossRefPubMed
4.
go back to reference Meenan R: Developing appropriate measures of the benefits of complementary and alternative medicine. Journal of Health Services Research and Policy. 2001, 6: 38-43. 10.1258/1355819011927189.CrossRefPubMed Meenan R: Developing appropriate measures of the benefits of complementary and alternative medicine. Journal of Health Services Research and Policy. 2001, 6: 38-43. 10.1258/1355819011927189.CrossRefPubMed
5.
go back to reference Robinson N, Donaldson J, Watt H: Auditing outcomes and costs of integrated complementary medicine provision - the importance of length of follow up. Complementary Therapies in Clinical Practice. 2006, 12: 249-257. 10.1016/j.ctcp.2006.07.007.CrossRefPubMed Robinson N, Donaldson J, Watt H: Auditing outcomes and costs of integrated complementary medicine provision - the importance of length of follow up. Complementary Therapies in Clinical Practice. 2006, 12: 249-257. 10.1016/j.ctcp.2006.07.007.CrossRefPubMed
6.
go back to reference Herman P, Craig B, Caspi O: Is complementary and alternative medicine (CAM) cost-effective? A systematic review. BMC Complementary and Alternative Medicine. 2005, 5: 11-10.1186/1472-6882-5-11.CrossRefPubMedPubMedCentral Herman P, Craig B, Caspi O: Is complementary and alternative medicine (CAM) cost-effective? A systematic review. BMC Complementary and Alternative Medicine. 2005, 5: 11-10.1186/1472-6882-5-11.CrossRefPubMedPubMedCentral
7.
go back to reference Thompson T, Feder G: Complementary therapies and the NHS: uncertain evidence of cost effectiveness should not exclude complementary medicine from reviews and guidelines. British Medical Journal. 2005, 331: 856-857. 10.1136/bmj.331.7521.856.CrossRefPubMedPubMedCentral Thompson T, Feder G: Complementary therapies and the NHS: uncertain evidence of cost effectiveness should not exclude complementary medicine from reviews and guidelines. British Medical Journal. 2005, 331: 856-857. 10.1136/bmj.331.7521.856.CrossRefPubMedPubMedCentral
8.
go back to reference Andrews GJ: Addressing efficiency: Economic evaluation and the agenda for CAM researchers. Complementary Therapies in Clinical Practice. 2005, 11: 253-261. 10.1016/j.ctcp.2005.04.001.CrossRefPubMed Andrews GJ: Addressing efficiency: Economic evaluation and the agenda for CAM researchers. Complementary Therapies in Clinical Practice. 2005, 11: 253-261. 10.1016/j.ctcp.2005.04.001.CrossRefPubMed
9.
go back to reference Dalziel K, Segal L, Mortimer D: Review of Australian health economic evaluation - 245 interventions: what can we say about cost effectiveness?. Cost Effectiveness and Resource Allocation. 2008, 6: 9-10.1186/1478-7547-6-9.CrossRefPubMedPubMedCentral Dalziel K, Segal L, Mortimer D: Review of Australian health economic evaluation - 245 interventions: what can we say about cost effectiveness?. Cost Effectiveness and Resource Allocation. 2008, 6: 9-10.1186/1478-7547-6-9.CrossRefPubMedPubMedCentral
10.
go back to reference Canter P, Thompson-Coon J, Ernst E: Cost effectiveness of complementary treatments in the United Kingdom: a systematic review. British Medical Journal. 2005, 331: 880-881. 10.1136/bmj.38625.575903.79.CrossRefPubMedPubMedCentral Canter P, Thompson-Coon J, Ernst E: Cost effectiveness of complementary treatments in the United Kingdom: a systematic review. British Medical Journal. 2005, 331: 880-881. 10.1136/bmj.38625.575903.79.CrossRefPubMedPubMedCentral
11.
go back to reference Coulter I: Integration and paradigm clash: The practical difficulties of integrative medicine. The mainstreaming of complementary and alternative medicine: Studies in social context. Edited by: Tovey P, Easthope G, Adams J. 2004, London: Routledge Coulter I: Integration and paradigm clash: The practical difficulties of integrative medicine. The mainstreaming of complementary and alternative medicine: Studies in social context. Edited by: Tovey P, Easthope G, Adams J. 2004, London: Routledge
12.
go back to reference Cookson R: Willingness to pay methods in health care: a sceptical view. Health Economics. 2003, 12: 891-894. 10.1002/hec.847.CrossRefPubMed Cookson R: Willingness to pay methods in health care: a sceptical view. Health Economics. 2003, 12: 891-894. 10.1002/hec.847.CrossRefPubMed
13.
go back to reference Brazier J, Deverill M, Green C, Harper R, Booth A: A review of the use of health status measures in economic evaluation. Health Technology Assessment. 1999, 3: Brazier J, Deverill M, Green C, Harper R, Booth A: A review of the use of health status measures in economic evaluation. Health Technology Assessment. 1999, 3:
14.
go back to reference Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL: Methods for the economic evaluation of health care programmes. 2007, Oxford: Oxford University Press, Third Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL: Methods for the economic evaluation of health care programmes. 2007, Oxford: Oxford University Press, Third
15.
go back to reference Torrance GW, Feeny D: Utilities and quality-adjusted life years. International Journal of Technology Assessment in Health Care. 1989, 5: 559-575. 10.1017/S0266462300008461.CrossRefPubMed Torrance GW, Feeny D: Utilities and quality-adjusted life years. International Journal of Technology Assessment in Health Care. 1989, 5: 559-575. 10.1017/S0266462300008461.CrossRefPubMed
16.
go back to reference Briggs A, Sculpher M: An introduction to Markov modelling for economic evaluation. Pharmacoeconomics. 1998, 13: 397-409. 10.2165/00019053-199813040-00003.CrossRefPubMed Briggs A, Sculpher M: An introduction to Markov modelling for economic evaluation. Pharmacoeconomics. 1998, 13: 397-409. 10.2165/00019053-199813040-00003.CrossRefPubMed
17.
go back to reference Gohler A, Geisler BP, Manne J, Kosiborod M, Zhang Z, Weintraub WS, Spertus J, Gazelle GS, Siebert U, Cohen D: Utility estimates for decision-analytic modelling in chronic heart failure: health states based on New York heart association classes and number of rehospitalisations. Value in Health. 2009, 12: 185-187. 10.1111/j.1524-4733.2008.00425.x.CrossRefPubMed Gohler A, Geisler BP, Manne J, Kosiborod M, Zhang Z, Weintraub WS, Spertus J, Gazelle GS, Siebert U, Cohen D: Utility estimates for decision-analytic modelling in chronic heart failure: health states based on New York heart association classes and number of rehospitalisations. Value in Health. 2009, 12: 185-187. 10.1111/j.1524-4733.2008.00425.x.CrossRefPubMed
18.
go back to reference Loomes G, McKenzie L: The use of QALYs in health care decision making. Social Science Medicine. 1989, 28: 299-308. 10.1016/0277-9536(89)90030-0.CrossRefPubMed Loomes G, McKenzie L: The use of QALYs in health care decision making. Social Science Medicine. 1989, 28: 299-308. 10.1016/0277-9536(89)90030-0.CrossRefPubMed
19.
go back to reference Broome J: QALYs. Journal of Public Economics. 1993, 50: 149-167. 10.1016/0047-2727(93)90047-W.CrossRef Broome J: QALYs. Journal of Public Economics. 1993, 50: 149-167. 10.1016/0047-2727(93)90047-W.CrossRef
20.
go back to reference Williams A: Economics, QALYs and medical ethics: a health economist's perspective. Health Care Analysis. 1995, 3: 221-234. 10.1007/BF02197671.CrossRefPubMed Williams A: Economics, QALYs and medical ethics: a health economist's perspective. Health Care Analysis. 1995, 3: 221-234. 10.1007/BF02197671.CrossRefPubMed
21.
go back to reference Krupnick AJ: Valuing health outcomes: policy choices and technical issues. 2004, Washington: Resources for the Future Krupnick AJ: Valuing health outcomes: policy choices and technical issues. 2004, Washington: Resources for the Future
22.
go back to reference Briggs A, Sculpher M, Claxton K: Decision modelling for health economic evaluation. 2006, Oxford: Oxford University Press Briggs A, Sculpher M, Claxton K: Decision modelling for health economic evaluation. 2006, Oxford: Oxford University Press
23.
go back to reference Sculpher M, Claxton K, Drummond MF, McCabe C: Whither trial-based economic evaluation for health care decision making?. Health Economics. 2006, 15: 677-687. 10.1002/hec.1093.CrossRefPubMed Sculpher M, Claxton K, Drummond MF, McCabe C: Whither trial-based economic evaluation for health care decision making?. Health Economics. 2006, 15: 677-687. 10.1002/hec.1093.CrossRefPubMed
24.
go back to reference Claxton K, Sculpher M, Drummond MF: A rational framework for decision making by the national institute for clinical excellence (NICE). The Lancet. 2002, 360: 711-715. 10.1016/S0140-6736(02)09832-X.CrossRef Claxton K, Sculpher M, Drummond MF: A rational framework for decision making by the national institute for clinical excellence (NICE). The Lancet. 2002, 360: 711-715. 10.1016/S0140-6736(02)09832-X.CrossRef
25.
go back to reference Buxton MJ, Drummond MF, Van Hout BA, Prince RL, Sheldon TA, Szucs T, Vray M: Modelling in economic evaluation: an unavoidable fact of life. Health Economics. 1997, 6: 217-227. 10.1002/(SICI)1099-1050(199705)6:3<217::AID-HEC267>3.0.CO;2-W.CrossRefPubMed Buxton MJ, Drummond MF, Van Hout BA, Prince RL, Sheldon TA, Szucs T, Vray M: Modelling in economic evaluation: an unavoidable fact of life. Health Economics. 1997, 6: 217-227. 10.1002/(SICI)1099-1050(199705)6:3<217::AID-HEC267>3.0.CO;2-W.CrossRefPubMed
26.
go back to reference Cooper N, Coyle D, Abrams K, Mugford M, Sutton A: Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997. Journal of Health Services Research and Policy. 2005, 10: 245-250. 10.1258/135581905774414187.CrossRefPubMed Cooper N, Coyle D, Abrams K, Mugford M, Sutton A: Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997. Journal of Health Services Research and Policy. 2005, 10: 245-250. 10.1258/135581905774414187.CrossRefPubMed
27.
go back to reference Higgins JPT, Green S, (Eds.): Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. 2008, The Cochrane Collaboration Higgins JPT, Green S, (Eds.): Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. 2008, The Cochrane Collaboration
28.
go back to reference Sutton A, Abrams K: Bayesian methods in meta-analysis and evidence synthesis. Statistical Methods in Medical Research. 2001, 10: 277-303. 10.1191/096228001678227794.CrossRefPubMed Sutton A, Abrams K: Bayesian methods in meta-analysis and evidence synthesis. Statistical Methods in Medical Research. 2001, 10: 277-303. 10.1191/096228001678227794.CrossRefPubMed
29.
go back to reference Taylor R, Drummond MF, Salkeld G, Sullivan S: Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. British Medical Journal. 2004, 329: 972-975. 10.1136/bmj.329.7472.972.CrossRefPubMedPubMedCentral Taylor R, Drummond MF, Salkeld G, Sullivan S: Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. British Medical Journal. 2004, 329: 972-975. 10.1136/bmj.329.7472.972.CrossRefPubMedPubMedCentral
30.
go back to reference Rich MW, Nease RF: Cost-effectiveness analysis in clinical practice: the case of heart failure. Archives of Internal Medicine. 1999, 159: 1690-1700. 10.1001/archinte.159.15.1690.CrossRefPubMed Rich MW, Nease RF: Cost-effectiveness analysis in clinical practice: the case of heart failure. Archives of Internal Medicine. 1999, 159: 1690-1700. 10.1001/archinte.159.15.1690.CrossRefPubMed
31.
go back to reference Weinstein M: How much are Americans willing to pay for a quality-adjusted life year?. Medical Care. 2008, 46: 343-345. 10.1097/MLR.0b013e31816a7144.CrossRefPubMed Weinstein M: How much are Americans willing to pay for a quality-adjusted life year?. Medical Care. 2008, 46: 343-345. 10.1097/MLR.0b013e31816a7144.CrossRefPubMed
32.
go back to reference Rawlins M, Culyer A: National institute for clinical excellence and its value judgements. British Medical Journal. 2004, 329: 224-227. 10.1136/bmj.329.7459.224.CrossRefPubMedPubMedCentral Rawlins M, Culyer A: National institute for clinical excellence and its value judgements. British Medical Journal. 2004, 329: 224-227. 10.1136/bmj.329.7459.224.CrossRefPubMedPubMedCentral
33.
go back to reference Trueman P, Drummond MF, Hutton J: Developing guidance for budget impact analysis. Pharmacoeconomics. 2001, 19: 609-621. 10.2165/00019053-200119060-00001.CrossRefPubMed Trueman P, Drummond MF, Hutton J: Developing guidance for budget impact analysis. Pharmacoeconomics. 2001, 19: 609-621. 10.2165/00019053-200119060-00001.CrossRefPubMed
34.
go back to reference Madden L, King L, Shiell A: How do government health departments in Australia access health economics advice to inform decisions for health? A survey. Australia and New Zealand Health Policy. 2009, 6: 6-10.1186/1743-8462-6-6.CrossRefPubMedPubMedCentral Madden L, King L, Shiell A: How do government health departments in Australia access health economics advice to inform decisions for health? A survey. Australia and New Zealand Health Policy. 2009, 6: 6-10.1186/1743-8462-6-6.CrossRefPubMedPubMedCentral
35.
go back to reference Drummond MF: Economic evaluation in health care: is it really useful or are we just kidding ourselves?. The Australian Economic Review. 2004, 37: 3-11. 10.1111/j.1467-8462.2004.00304.x.CrossRef Drummond MF: Economic evaluation in health care: is it really useful or are we just kidding ourselves?. The Australian Economic Review. 2004, 37: 3-11. 10.1111/j.1467-8462.2004.00304.x.CrossRef
36.
go back to reference Clement F, Harris A, Li JJ, Yong K, Lee K, Manns B: Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. Journal of the Amerian Medical Association. 2009, 302: 1437-1443. 10.1001/jama.2009.1409.CrossRef Clement F, Harris A, Li JJ, Yong K, Lee K, Manns B: Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. Journal of the Amerian Medical Association. 2009, 302: 1437-1443. 10.1001/jama.2009.1409.CrossRef
37.
go back to reference Jackson T: Health technology assessment in Australia: challenges ahead. Medical Journal of Australia. 2007, 187: 262-264.PubMed Jackson T: Health technology assessment in Australia: challenges ahead. Medical Journal of Australia. 2007, 187: 262-264.PubMed
38.
go back to reference Meenan R, Vuckovic N: On the integration of complementary and conventional medicine within health maintenance organisations. Journal of Ambulatory Care Management. 2003, 27: 43-52.CrossRef Meenan R, Vuckovic N: On the integration of complementary and conventional medicine within health maintenance organisations. Journal of Ambulatory Care Management. 2003, 27: 43-52.CrossRef
39.
go back to reference Graves N: What do we know about complementary medicine? What should we know?. Journal of Health Services Research and Policy. 1996, 1: 169-170.PubMed Graves N: What do we know about complementary medicine? What should we know?. Journal of Health Services Research and Policy. 1996, 1: 169-170.PubMed
Metadata
Title
The use of economic evaluation in CAM: an introductory framework
Authors
Emily Ford
Daniela Solomon
Jon Adams
Nicholas Graves
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2010
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-10-66

Other articles of this Issue 1/2010

BMC Complementary Medicine and Therapies 1/2010 Go to the issue